Initial Statement of Beneficial Ownership (3)
2022年8月23日 - 7:27AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Costantino Robert J |
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/16/2022
|
3. Issuer Name and Ticker or Trading Symbol
Cure Pharmaceutical Holding Corp. [CURR]
|
(Last)
(First)
(Middle)
1620 BEACON PLACE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
OXNARD, CA 93033
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 314090 | D (1) | |
Common Stock | 201867 | D (2) | |
Common Stock | 161800 | D (3) | |
Common Stock | 49100 | D (4) | |
Common Stock | 22400 | I (5) | By spouse's rollover IRA (5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | Held by the Reporting Person and his spouse as joint tenants. |
(2) | Held in a Roth IRA for the sole benefit of the Reporting Person. |
(3) | Held in a rollover IRA for the sole benefit of the Reporting Person. |
(4) | Held in brokerage accounts from which all dividends and other payments are made to the Reporting Person's daughters and with respect to which the Reporting Person is a joint tenant with a right of survivorship. |
(5) | Held in a Rollover IRA by the spouse of the Reporting Person. |
Remarks: Exhibit 24 - Power of Attorney |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Costantino Robert J 1620 BEACON PLACE OXNARD, CA 93033 | X |
|
|
|
Signatures
|
/s/ Joel M. Bennett, attorney-in-fact for Robert J. Costantino | | 8/19/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Cure Pharmaceutical (PK) (USOTC:CURR)
過去 株価チャート
から 5 2024 まで 6 2024
Cure Pharmaceutical (PK) (USOTC:CURR)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Cure Pharmaceutical Holding Corporation (PK) (その他OTC): 0 recent articles
その他のCure Pharmaceutical Holding Corp.ニュース記事